kund
2 minutes ago
Africa, Nigeria, or even some Middle Eastern countries, including Afghanistan, have great potential markets for an AD drug. Misleadingly, he's targeting lesser-known markets for 2-73, intending to follow a non-traditional path from drug development to marketing. He wants to go down in history.
rbtree
10 minutes ago
I've recently bought FSELX, and find that SMH has outperformed it over 1,3,5,and 10 years. Yes, the prices are high and may well pull back as they did recently, but the market is still hot and insatiable for more "AI"